Cambridge NeuroScience Incorporated

Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the nervous system.

Cambridge NeuroScience is focused in two areas of research and development: (i) ion-channel blockers to prevent or treat brain damage resulting from stroke and other forms of brain ischemia, as well as for the treatment or prevention of neuropathic pain, glaucoma, spinal cord injury, Parkinson's disease, multiple sclerosis ("MS") and peripheral neuropathies, and (ii) growth factors for the treatment of MS and peripheral neuropathies.

Contact Details: 333 Providence Highway Norwood MA 02062 United States of America Tel: 781-255-6700 Fax: 781-255-6711 Email: WWW: www.cambneuro.com/

Loading...

Recent Publications by Cambridge NeuroScience Incorporated:
Neuregulin signaling in brain injury and in animal models of ischemia. The identification and characterization of a potentially...	18th March, 2000	Cambridge NeuroScience, Inc., Massachusetts 02139, USA.	Ann N Y Acad Sci. 1999;890:355.

BioNews Results for Cambridge NeuroScience Incorporated:
Biovitrum to Acquire Swedish Orphan for Over $500M	Genetic Engineering News:  Nov 6 2009 6:05AM Matching: cambridge neuroscience
Proximagen delivers first deal - Acquisition of Cambridge Biotechnology	Pharma Live:  Nov 3 2009 7:17AM Matching: cambridge neuroscience
Proximagen Neuroscience to buy Cambridge Biotechnology from Biovitrum	Therapeutics Daily:  Oct 31 2009 12:24AM Matching: cambridge neuroscience
Swedish Biovitrum sells Cambridge Biotechnology to UK Proximagen Neuroscience	Therapeutics Daily:  Oct 31 2009 12:24AM Matching: cambridge neuroscience
Proximagen acquires Cambridge Biotechnology	Business Financial Newswire:  Oct 31 2009 2:52AM Matching: cambridge neuroscience
Promote your company here: BioNewsCast - Press Release Distribution	→View more Cambridge NeuroScience Incorporated news.

Cambridge NeuroScience Incorporated Patents:
US Patent No.	Title
5298657	Preparation of substituted guanidines
5670519	Acenaphthyl-substituted guanidines and methods of use thereof
5672608	Acenaphthyl substituted guanidines and methods of use thereof
5677348	Substituted aminoguanidines and methods of use thereof
5681568	Device for delivery of substances and methods of use thereof
→View more Cambridge NeuroScience Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 592 times since April 2007, the link to the organisation's website has been followed 148 times

Recent Search Terms used to find this page: cambridge neuroscience | Neuroscience incorporated | Cambridge NeuroScience Norwood Massachusetts United States | cambridge neur | Cambridge NeuroScience USA | Cambridge NeuroScience Inc. Cambridge MA AND online catalogue | cambridge neurosciences | cambridge neuroscience | cambridge Neuroscience patents | Cambridge Neuroscience | .

Search for more companies in Norwood

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cambridge NeuroScience Incorporated